Cas:72629-69-7 (1S,2Z,4E,8E,12E)-5,9,13-trimethyl-2-propan-2-ylcyclotetradeca-2,4,8,12-tetraen-1-ol manufacturer & supplier

We serve Chemical Name:(1S,2Z,4E,8E,12E)-5,9,13-trimethyl-2-propan-2-ylcyclotetradeca-2,4,8,12-tetraen-1-ol CAS:72629-69-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(1S,2Z,4E,8E,12E)-5,9,13-trimethyl-2-propan-2-ylcyclotetradeca-2,4,8,12-tetraen-1-ol

Chemical Name:(1S,2Z,4E,8E,12E)-5,9,13-trimethyl-2-propan-2-ylcyclotetradeca-2,4,8,12-tetraen-1-ol
CAS.NO:72629-69-7
Synonyms:2,4,8,12-Cyclotetradecatetraen-1-ol,5,9,13-trimethyl-2-(1-methylethyl)-,(S-(Z,E,E,E));sarcophytol-A;2,4,8,12-Cyclotetradecatetraen-1-ol,5,9,13-trimethyl-2-(1-methylethyl)-,(1S,2Z,4E,8E,12E);(1S,2Z,8E,12E)-5,9,13-trimethyl-2-(1-methylethyl)cyclotetradeca-2,4,8,12-tetraen-1-ol;reduced sarcophine
Molecular Formula:C20H32O
Molecular Weight:288.46700
HS Code:2906199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:415.4ºC at 760 mmHg
Density:0.894g/cm3
Index of Refraction:1.485
PSA:20.23000
Exact Mass:288.24500
LogP:5.73270

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,4,8,12-Cyclotetradecatetraen-1-ol,5,9,13-trimethyl-2-(1-methylethyl)-,(S-(Z,E,E,E)) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,reduced sarcophine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1S,2Z,8E,12E)-5,9,13-trimethyl-2-(1-methylethyl)cyclotetradeca-2,4,8,12-tetraen-1-ol Use and application,2,4,8,12-Cyclotetradecatetraen-1-ol,5,9,13-trimethyl-2-(1-methylethyl)-,(1S,2Z,4E,8E,12E) technical grade,usp/ep/jp grade.


Related News: Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm. (1S,2Z,4E,8E,12E)-5,9,13-trimethyl-2-propan-2-ylcyclotetradeca-2,4,8,12-tetraen-1-ol manufacturer Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. (1S,2Z,4E,8E,12E)-5,9,13-trimethyl-2-propan-2-ylcyclotetradeca-2,4,8,12-tetraen-1-ol supplier Unfortunately, PFAS are considered forever chemicals” because they don’t naturally degrade, Bruton said. Instead, they accumulate in the bodies of humans and animals. It’s believed that every single American has a detectable level of PFAS in their bodies.
Some PFAS chemicals have been shown to be toxic, potentially contributing to high cholesterol levels, low infant birth weights, immune deficiencies and thyroid gland disruptions, according to the EPA.
“The problem with these chemicals is they last a long time in the environment as well as in your body,” said Dr. Maaike van Gerwen, an assistant professor in the Institute of Translational Epidemiology at Mount Sinai in New York City. “We do not know exactly what the harm is of exposure to very low levels of these chemicals over a very long period of time, because these are a relatively new kind of chemical. (1S,2Z,4E,8E,12E)-5,9,13-trimethyl-2-propan-2-ylcyclotetradeca-2,4,8,12-tetraen-1-ol vendor Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. (1S,2Z,4E,8E,12E)-5,9,13-trimethyl-2-propan-2-ylcyclotetradeca-2,4,8,12-tetraen-1-ol factory Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost.